EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles
Year: 2020
Type: review
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: epidermal growth factor receptor, antibody-drug conjugates, antibody-nanoparticle conjugates, anti-EGFR monoclonal antibody, cetuximab, EGFR signaling, EGFR downregulation, enhanced permeability and retention effect, receptor-mediated endocytosis, nanoparticle drug delivery, receptor tyrosine kinase
Open Access status: closed
Awards: G6140948680, G7197806364, G799836774
OpenAlex ID: W3103758115
